Beaton Management Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Beaton Management Company's XBI Position: Q2 2026 in Review
Beaton Management Company held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,022 shares worth $320K. The position accounts for 0.13% of the portfolio, ranked #126.
Beaton Management Company first reported a position in XBI in Q2 2018 and has held it in 17 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Beaton Management Company held 2,022 shares of State Street SPDR S&P Biotech ETF worth $320K as of Q2 2026.
- Beaton Management Company left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.13% of Beaton Management Company's portfolio in Q2 2026, its #126 holding.
- Beaton Management Company first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 17 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Beaton Management Company's 13F filing for Q2 2026, filed 7 Aug 2026.